Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Ibrutinib in Previously Untreated Binet Stage a Chronic Lymphocytic Leukemia with Risk of Disease Progression
ClinicalTrials.gov study NCT02863718. IPD Sharing: NO. Countries: 1. Publications: 2.
Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05007860. IPD Sharing: YES. Countries: 1. Publications: 1.
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Trans
ClinicalTrials.gov study NCT00309881. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01419691. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation
ClinicalTrials.gov study NCT01455051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice
ClinicalTrials.gov study NCT03425591. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
ClinicalTrials.gov study NCT01638533. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04806035. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and
ClinicalTrials.gov study NCT01117142. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT00558961. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02007044. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00742144. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04964908. IPD Sharing: YES. Countries: 17. Publications: 1.
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
ClinicalTrials.gov study NCT04623541. IPD Sharing: NO. Countries: 13. Publications: 1.
The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00868478. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
ClinicalTrials.gov study NCT05183854. IPD Sharing: NO. Countries: 1. Publications: 0.
Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00082940. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00004857. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03455517. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01328626. IPD Sharing: NO. Countries: 2. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.